Expression of β-catenin and REG Iα in relation to cell proliferative ability in salivary gland tumors

Hakata,Yuko; Fukui,Hirokazu; Sekikawa,Akira; Yamagishi,Hidetsugu; Ichikawa,Kazuhito; Tomita,Shigeki; Imura,Johji; Kawamata,Hitoshi; Imai,Yutaka; Fujimori,Takahiro

doi:10.3892/etm_00000068

Expression of β-catenin and REG Iα in relation to cell proliferative ability in salivary gland tumors

Authors:
- Yuko Hakata
- Hirokazu Fukui
- Akira Sekikawa
- Hidetsugu Yamagishi
- Kazuhito Ichikawa
- Shigeki Tomita
- Johji Imura
- Hitoshi Kawamata
- Yutaka Imai
- Takahiro Fujimori
View Affiliations

Affiliations: Departments of Surgical and Molecular Pathology, and Oral Surgery, Dokkyo University School of Medicine, Tochigi 321-0293, Japan
Published online on: May 1, 2010 https://doi.org/10.3892/etm_00000068
Pages: 437-443

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

β-catenin and its target gene products have been thought to play pivotal roles in the progression of various neoplasias. In the present study, we examined the expression of β-catenin and regenerating gene (REG) Iα in salivary gland tumors and investigated its relationship to their cell proliferative ability. Nineteen patients with pleomorphic adenoma (PA) and 17 patients with malignant salivary gland tumors, including 7 adenoid cystic carcinomas, 7 mucoepidermoid carcinomas and 3 polymorphous low-grade adenocarcinomas, were enrolled. The specimens that had been surgically resected from these patients were examined using immunohistochemistry for β-catenin, REG Iα and Ki67. The relationships between clinicopathological features and β-catenin or REG Iα expression were then analyzed. β-catenin immunoreactivity was positive in 14 PAs (73.3%) and 14 malignant salivary gland tumors (82.4%). Four (28.6%) of the 14 β-catenin-positive PAs showed clear β-catenin immunoreactivity at the plasma membrane (membrane type), while 10 (71.4%) showed diffuse immunoreactivity in the cytoplasm and nucleus but not at the plasma membrane (non-membrane type). Twelve (85.9%) of the 14 malignant salivary gland tumors showed non-membrane-type β-catenin expression. Six (31.6%) of the 19 PAs and 10 (58.8%) of the 17 malignant salivary gland tumors were positive for REG Iα expression. PAs with non-membrane-type β-catenin expression showed a significantly higher Ki67 labeling index than PAs with negative or membrane-type expression. Additionally, PAs that were REG Iα-positive showed a significantly higher Ki67 labeling index than those that were negative. Non-membrane-type β-catenin expression was related to REG Iα positivity in PA lesions. β-catenin and its associated REG Iα protein may play a role as growth?promoting factors in the development of salivary gland tumors.

View Figures

View References

1.	Eveson JW and Cawson RA: Salivary gland tumours: a review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 146:51–58. 1985. View Article : Google Scholar : PubMed/NCBI
2.	Cheuk W and Chan JKC: Advances in salivary gland pathology. Histopathology. 51:1–20. 2007. View Article : Google Scholar
3.	Altemani A, Martins MT, Fretias L, Soares F, Araujo NS and Araujo VC: Carcinoma ex-pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology. 46:635–641. 2005. View Article : Google Scholar : PubMed/NCBI
4.	Speight PM and Barrett AW: Salivary gland tumours. Oral Dis. 8:229–240. 2002. View Article : Google Scholar : PubMed/NCBI
5.	Carvalho AL, Nishimoto IN, Califano JA and Kowalski LP: Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
6.	Shibuya Y, Ri S, Umeda M, Yoshikawa T, Masago H and Komori T: Ultrastructural localization of E-cadherin and α-/β-catenin in adenoid cystic carcinoma. Histopathology. 35:423–431. 1999.
7.	Prado RF, Consolaro A and Taveira LAA: Expression of β-catenin in carcinoma in pleomorphic adenoma, pleomorphic adenoma and normal salivary gland: immunohistochemical study. Oral Med Pathol. 11:E247–E251. 2006.
8.	Furuse C, Cury PR, Altemani A, dos Santos Pinto D Jr, de Araújo NS and de Araújo VC: β-catenin and E-cadherin expression in salivary gland tumors. Int J Sur Pathol. 14:212–217. 2006.
9.	Genelhu MC, Gobbi H, Arantes DC, Cardoso SV and Cassali D: Immunolocalization of β-catenin in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands. Appl Immunohistochem Mol Morphol. 15:273–278. 2007.
10.	Ferrazzo KL, Neto MM, dos Santos E, dos Santos Pinto D and de Sousa SO: Differential expression of galectin-3, β-catenin and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands. J Oral Pathol Med. 38:701–707. 2009.
11.	Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T and Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinoma in male and female mice. Cell. 55:619–625. 1988. View Article : Google Scholar : PubMed/NCBI
12.	Roose J, Huls G, van Beest M, et al: Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 285:1923–1926. 1999. View Article : Google Scholar : PubMed/NCBI
13.	Stepanova L, Finegold M, DeMayo F, Schmidt EV and Harper JW: The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol. 20:4462–4473. 2000. View Article : Google Scholar : PubMed/NCBI
14.	Terazono K, Yamamoto H, Takasawa S, et al: A novel gene activated in regenerating islets. J Biol Chem. 263:2111–2114. 1988.PubMed/NCBI
15.	Watanabe T, Yonekura H, Terazono K, Yamamoto H and Okamoto H: Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. J Biol Chem. 265:7432–7439. 1990.PubMed/NCBI
16.	Asahara M, Mushiake S, Shimada S, et al: Reg gene expression is increased in rat gastric enterochromaffin-like cells following water immersion stress. Gastroenterology. 111:45–55. 1996. View Article : Google Scholar
17.	Fukui H, Fujii S, Takeda J, et al: Expression of Reg Iα in human gastric cancers. Digestion. 69:177–184. 2004.
18.	Astrosini C, Roeefzaad C, Dai YY, Dieckgraefe BK, Jöns T and Kemmner W: REG1A expression is a prognostic marker in colorectal cancer and associated with peritoneal carcinomatosis. Int J Cancer. 123:409–413. 2008. View Article : Google Scholar
19.	Minamiya Y, Kawai H, Saito H, et al: REG1A expression is an independent factor predictive of poor prognosis in patients with non-small cell lung cancer. Lung Cancer. 60:98–104. 2008. View Article : Google Scholar : PubMed/NCBI
20.	Mauro V, Carette D, Chevallier D, et al: Reg I protein in healthy and seminoma human testis. Histol Histopathol. 23:1195–1203. 2008.PubMed/NCBI
21.	Fukui H, Franceschi F, Penland RL, et al: Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. Lab Invest. 83:1777–1786. 2003.
22.	Fukui H, Kinoshita Y, Maekawa T, et al: Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology. 115:1483–1493. 1998. View Article : Google Scholar : PubMed/NCBI
23.	Sekikawa A, Fukui H, Fujii S, et al: REG Iα protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology. 128:642–653. 2005.
24.	Sekikawa A, Fukui H, Fujii S, et al: Possible role of REG Iα protein in ulcerative colitis and colitic cancer. Gut. 54:1437–1444. 2005.
25.	Cavard C, Terris B and Grimber G: et al Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene. 25:599–608. 2006. View Article : Google Scholar : PubMed/NCBI
26.	Yuan RH, Jeng YM, Chen HL, et al: Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. Clin Cancer Res. 11:2568–2575. 2005. View Article : Google Scholar
27.	Kimura T, Fukui H, Sekikawa A, et al: Involvement of REG Iα protein in the regeneration of ductal epithelial cells in the minor salivary glands of patients with Sjögren's syndrome. Clin Exp Immunol. 155:16–20. 2009.
28.	Sasahira T, Oue N, Kirita T, et al: Reg IV expression is associated with cell growth and prognosis of denoid cystic carcinoma in the salivary gland. Histopathology. 53:667–675. 2008. View Article : Google Scholar : PubMed/NCBI
29.	Gerdes J, Li L, Schlueter C, et al: Immunohistochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol. 138:867–873. 1991.PubMed/NCBI
30.	Van Aken E, De Wever O and Correia da Rocha AS: Defective E-cadherin/catenin complexes in human cancer. Virchows Arch. 439:725–751. 2001.PubMed/NCBI
31.	Mosimann C, Hausmann G and Basler K: β-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol. 10:276–286. 2009.
32.	Kadowaki Y, Ishihara S, Miyaoka Y, et al: Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. FEBS Lett. 530:59–64. 2002. View Article : Google Scholar